#ARDS. Approach the #ICU monster with an organized thought.
#MedTwitter #CriticalCare #ventilators #twittorial #respiratory_therapy
#COVID
(1/10)
Acute respiratory distress syndrome is an impairment of alveolar-interstatium capillary-relationship + an inflammatory distruction.
Berlin definition has an objective criteria so all teams can speak a common language.
(2/10)
A protein rich inflammatory fluid will fill the airspace (so called wet lung) in a heterogeneous distribution.
(3/10)
This will result in:
- impair gas exchange
- smaller aireated area (baby lung)
- decrease lung compliance (so called stiff lung)
- pulmonary hypertension.
(4/10)
Management is divided into:
- ventilator management
- non- ventilator (pharmacological and non-pharmaceutical) management.
(5/10)
Lung protecive ventilation with halmark of low tidal volume, targeted platue pressure(<30) and using optimal PEEP.
ARDS network (ARMA) trial was the landmark fot that.
You can review choosing optimal PEEP here. https://twitter.com/Mosapositive/status/1280483859637862400?s=19
(6/10)
Non pharmacological mainly is positional management i.e prone ventilation.
Look for it there https://twitter.com/Mosapositive/status/1290709292153176066?s=19
(7/10)
Pharmacological intervention include:
Nueromuscular blocking agent.
The last evidence from a large Meta-analysis of RCTs doesn't recommend routine use but in case once deep sedation is needed. (keep in mind the difference between bolus Vs infusion)
(8/10)
Conservative fluid management (despite volume status) is preferred although mortality benefit is not clear.
FACTT trial was the one looking for.
(9/10)
Steroid use is still controversial with different suggested regimen.
(10/10)
N.B:
More important is to manage the underlying cause.
Rescue therapies are beyond the aim of this thread.

The end.
You can follow @Mosapositive.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: